FDA Inspection 1031863 — CSL Behring LLC
The FDA completed an inspection of CSL Behring LLC on Nov 9, 2017 in King Of Prussia, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 9, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- King Of Prussia, PA (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)